 LEXINGTON, Mass and AMSTERDAM, Dec. 02, 2020 GLOBE NEWSWIRE -- uniQure N.V. NASDAQ: QURE, a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that its participation in the following upcoming virtual investor and scientific conferences: 